ID   GALT4_HUMAN             Reviewed;         578 AA.
AC   Q8N4A0; B2R775; B4DMX6; O00208;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 2.
DT   10-MAY-2017, entry version 124.
DE   RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 4;
DE            EC=2.4.1.41;
DE   AltName: Full=Polypeptide GalNAc transferase 4;
DE            Short=GalNAc-T4;
DE            Short=pp-GaNTase 4;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase 4;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4;
GN   Name=GALNT4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ENZYME ACTIVITY, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND VARIANT ILE-506.
RX   PubMed=9804815; DOI=10.1074/jbc.273.46.30472;
RA   Bennett E.P., Hassan H., Mandel U., Mirgorodskaya E., Roepstorff P.,
RA   Burchell J., Taylor-Papadimitriou J., Hollingsworth M.A., Merkx G.,
RA   van Kessel A.G., Eiberg H., Steffensen R., Clausen H.;
RT   "Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-
RT   acetylgalactosaminyltransferase that complements other GalNAc-
RT   transferases in complete O-glycosylation of the MUC1 tandem repeat.";
RL   J. Biol. Chem. 273:30472-30481(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS THR-270 AND ILE-506.
RC   TISSUE=Kidney, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLY-51.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   DOMAIN, AND MUTAGENESIS OF ASP-459.
RX   PubMed=10984485; DOI=10.1074/jbc.M005783200;
RA   Hassan H., Reis C.A., Bennett E.P., Mirgorodskaya E., Roepstorff P.,
RA   Hollingsworth M.A., Burchell J., Taylor-Papadimitriou J., Clausen H.;
RT   "The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptide N-
RT   acetylgalactosaminyltransferase-T4 directs its glycopeptide
RT   specificities.";
RL   J. Biol. Chem. 275:38197-38205(2000).
CC   -!- FUNCTION: Catalyzes the initial reaction in O-linked
CC       oligosaccharide biosynthesis, the transfer of an N-acetyl-D-
CC       galactosamine residue to a serine or threonine residue on the
CC       protein receptor. Has a highest activity toward Muc7, EA2 and
CC       Muc2, with a lowest activity than GALNT2. Glycosylates 'Thr-57' of
CC       SELPLG.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-galactosamine +
CC       polypeptide = UDP + N-acetyl-alpha-D-galactosaminyl-polypeptide.
CC       {ECO:0000269|PubMed:9804815}.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000305|PubMed:9804815}; Single-pass type II membrane protein
CC       {ECO:0000305|PubMed:9804815}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8N4A0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N4A0-2; Sequence=VSP_045009, VSP_045010;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highly expressed in mucous cells.
CC       {ECO:0000269|PubMed:9804815}.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif),
CC       which is probably involved in manganese coordination and substrate
CC       binding and the C-terminal domain (domain B, also called
CC       Gal/GalNAc-T motif), which is probably involved in catalytic
CC       reaction and UDP-Gal binding. {ECO:0000250}.
CC   -!- DOMAIN: The ricin B-type lectin domain directs the glycopeptide
CC       specificity. It is required in the glycopeptide specificity of
CC       enzyme activity but not for activity with naked peptide
CC       substrates, suggesting that it triggers the catalytic domain to
CC       act on GalNAc-glycopeptide substrates.
CC       {ECO:0000269|PubMed:10984485}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Polypeptide N-acetylgalactosaminyltransferase 4;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_486";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y08564; CAA69875.1; -; Genomic_DNA.
DR   EMBL; AK297677; BAG60038.1; -; mRNA.
DR   EMBL; AK312870; BAG35722.1; -; mRNA.
DR   EMBL; AC010201; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025034; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC036390; AAH36390.1; -; mRNA.
DR   CCDS; CCDS53817.1; -. [Q8N4A0-1]
DR   RefSeq; NP_001186711.1; NM_001199782.1. [Q8N4A0-2]
DR   RefSeq; NP_003765.2; NM_003774.4. [Q8N4A0-1]
DR   UniGene; Hs.25130; -.
DR   ProteinModelPortal; Q8N4A0; -.
DR   SMR; Q8N4A0; -.
DR   BioGrid; 114240; 9.
DR   BioGrid; 1529357; 1.
DR   STRING; 9606.ENSP00000436604; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   iPTMnet; Q8N4A0; -.
DR   PhosphoSitePlus; Q8N4A0; -.
DR   SwissPalm; Q8N4A0; -.
DR   BioMuta; GALNT4; -.
DR   DMDM; 338817878; -.
DR   EPD; Q8N4A0; -.
DR   MaxQB; Q8N4A0; -.
DR   PaxDb; Q8N4A0; -.
DR   PeptideAtlas; Q8N4A0; -.
DR   PRIDE; Q8N4A0; -.
DR   DNASU; 8693; -.
DR   Ensembl; ENST00000529983; ENSP00000436604; ENSG00000257594. [Q8N4A0-1]
DR   GeneID; 100528030; -.
DR   GeneID; 8693; -.
DR   KEGG; hsa:100528030; -.
DR   KEGG; hsa:8693; -.
DR   UCSC; uc001tbd.4; human. [Q8N4A0-1]
DR   CTD; 100528030; -.
DR   CTD; 8693; -.
DR   DisGeNET; 8693; -.
DR   GeneCards; GALNT4; -.
DR   HGNC; HGNC:4126; GALNT4.
DR   HPA; HPA076116; -.
DR   MIM; 603565; gene.
DR   neXtProt; NX_Q8N4A0; -.
DR   OpenTargets; ENSG00000257594; -.
DR   PharmGKB; PA28539; -.
DR   eggNOG; KOG3736; Eukaryota.
DR   eggNOG; ENOG410XPMK; LUCA.
DR   GeneTree; ENSGT00760000118828; -.
DR   HOGENOM; HOG000038227; -.
DR   HOVERGEN; HBG051699; -.
DR   InParanoid; Q8N4A0; -.
DR   KO; K00710; -.
DR   OMA; ISLHRHI; -.
DR   OrthoDB; EOG091G085O; -.
DR   PhylomeDB; Q8N4A0; -.
DR   TreeFam; TF352660; -.
DR   BRENDA; 2.4.1.41; 2681.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   UniPathway; UPA00378; -.
DR   PRO; PR:Q8N4A0; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   CleanEx; HS_GALNT4; -.
DR   Genevisible; Q8N4A0; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; TAS:ProtInc.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; TAS:Reactome.
DR   GO; GO:0005975; P:carbohydrate metabolic process; NAS:ProtInc.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disulfide bond; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Lectin; Manganese; Membrane;
KW   Metal-binding; Polymorphism; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    578       Polypeptide N-
FT                                acetylgalactosaminyltransferase 4.
FT                                /FTId=PRO_0000059108.
FT   TOPO_DOM      1     12       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     13     35       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     36    578       Lumenal. {ECO:0000255}.
FT   DOMAIN      444    577       Ricin B-type lectin.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   REGION      134    243       Catalytic subdomain A.
FT   REGION      303    365       Catalytic subdomain B.
FT   METAL       227    227       Manganese. {ECO:0000250}.
FT   METAL       229    229       Manganese. {ECO:0000250}.
FT   METAL       362    362       Manganese. {ECO:0000250}.
FT   BINDING     175    175       Substrate. {ECO:0000250}.
FT   BINDING     204    204       Substrate. {ECO:0000250}.
FT   BINDING     334    334       Substrate. {ECO:0000250}.
FT   BINDING     370    370       Substrate. {ECO:0000250}.
FT   CARBOHYD    471    471       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    124    357       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    348    421       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    457    477       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    503    518       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    547    565       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   VAR_SEQ       1    120       MAVRWTWAGKSCLLLAFLTVAYIFVELLVSTFHASAGAGRA
FT                                RELGSRRLSDLQKNTEDLSRPLYKKPPADSRALGEWGKASK
FT                                LQLNEDELKQQEELIERYAINIYLSDRISLHRHIEDKR ->
FT                                MAWCVATADPAHTSRPLFTGLAVSRGSAGHAWSAGFDWAAV
FT                                VVVTGRRCRSGQTVPGAARSPLLPHPLPSPLRVPPPTGALG
FT                                RPLPRWPQPRRTPFWSVISKATKLRSPPWTSAPTASNL
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045009.
FT   VAR_SEQ     121    292       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045010.
FT   VARIANT      51     51       D -> G (in dbSNP:rs17853610).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_065257.
FT   VARIANT     270    270       I -> T (in dbSNP:rs2230281).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_019576.
FT   VARIANT     506    506       V -> I (in dbSNP:rs2230283).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:9804815}.
FT                                /FTId=VAR_019577.
FT   MUTAGEN     459    459       D->H: Affects the glycopeptide
FT                                specificity and abolishes ability to
FT                                glycosylate Muc1, Muc2 and Muc5AC.
FT                                {ECO:0000269|PubMed:10984485}.
FT   CONFLICT     11     11       S -> T (in Ref. 1; CAA69875).
FT                                {ECO:0000305}.
FT   CONFLICT    227    227       D -> Y (in Ref. 1; CAA69875).
FT                                {ECO:0000305}.
FT   CONFLICT    247    247       D -> Y (in Ref. 1; CAA69875).
FT                                {ECO:0000305}.
SQ   SEQUENCE   578 AA;  66666 MW;  6EEEF502A40CBD2E CRC64;
     MAVRWTWAGK SCLLLAFLTV AYIFVELLVS TFHASAGAGR ARELGSRRLS DLQKNTEDLS
     RPLYKKPPAD SRALGEWGKA SKLQLNEDEL KQQEELIERY AINIYLSDRI SLHRHIEDKR
     MYECKSQKFN YRTLPTTSVI IAFYNEAWST LLRTIHSVLE TSPAVLLKEI ILVDDLSDRV
     YLKTQLETYI SNLDRVRLIR TNKREGLVRA RLIGATFATG DVLTFLDCHC ECNSGWLEPL
     LERIGRDETA VVCPVIDTID WNTFEFYMQI GEPMIGGFDW RLTFQWHSVP KQERDRRISR
     IDPIRSPTMA GGLFAVSKKY FQYLGTYDTG MEVWGGENLE LSFRVWQCGG KLEIHPCSHV
     GHVFPKRAPY ARPNFLQNTA RAAEVWMDEY KEHFYNRNPP ARKEAYGDIS ERKLLRERLR
     CKSFDWYLKN VFPNLHVPED RPGWHGAIRS RGISSECLDY NSPDNNPTGA NLSLFGCHGQ
     GGNQFFEYTS NKEIRFNSVT ELCAEVPEQK NYVGMQNCPK DGFPVPANII WHFKEDGTIF
     HPHSGLCLSA YRTPEGRPDV QMRTCDALDK NQIWSFEK
//
